secondary acute myeloid leukemia
GPTKB entity
Statements (50)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:Oncology
|
| gptkbp:age_group |
adults
elderly |
| gptkbp:anatomy |
myeloid cells
|
| gptkbp:associated_with |
gptkb:myelodysplastic_syndromes
myeloproliferative disorders |
| gptkbp:caused_by |
previous cancer treatment
|
| gptkbp:characterized_by |
abnormal blood cell production
|
| gptkbp:clinical_trial |
Phase IV
Phase II Phase III Phase I |
| gptkbp:complication |
infections
organ failure bleeding disorders |
| gptkbp:death |
lower than primary AML
|
| gptkbp:diagnosis |
gptkb:chronic_myeloid_leukemia
gptkb:myelodysplastic_syndromes gptkb:Oncology blood tests varies by individual bone marrow biopsy acute promyelocytic leukemia |
| gptkbp:events |
regular monitoring
supportive care |
| gptkbp:genetic_studies |
gptkb:FLT3
gptkb:NPM1 gptkb:TP53 gptkb:DNMT3_A |
| https://www.w3.org/2000/01/rdf-schema#label |
secondary acute myeloid leukemia
|
| gptkbp:is_common_in |
patients with prior cancer
|
| gptkbp:occurs_in |
primary malignancy
|
| gptkbp:research_focus |
patient outcomes
genetic factors treatment strategies |
| gptkbp:risk_factor |
radiation therapy
genetic predisposition previous chemotherapy |
| gptkbp:symptoms |
fatigue
weight loss fever easy bruising |
| gptkbp:treatment |
clinical trials
chemotherapy targeted therapy relapse remission stem cell transplant |
| gptkbp:bfsParent |
gptkb:ASXL1
|
| gptkbp:bfsLayer |
6
|